Skip to content
Evigrade
MinorDirect oral anticoagulants (factor Xa inhibitors)×Botanical supplement, black seed oil (Nigella sativa, thymoquinone); no EMA HMPC monograph

Updated · Methodology

Mechanism

Apixaban is metabolised mainly by CYP3A4 and its elimination involves P-glycoprotein. According to its SmPC, strong inhibitors of both pathways are not recommended. Substances that are not strong inhibitors raise apixaban levels less and need no apixaban dose adjustment: diltiazem, for example, increased apixaban exposure 1.4-fold (Eliquis SmPC, European Medicines Agency, EMA, section 4.5). Antiplatelet agents taken with apixaban increase the risk of bleeding (Eliquis SmPC, EMA, section 4.4). Black seed is a plant whose oil and seeds are sold as food supplements. It is not authorised as a medicine in Spain. In 4 healthy volunteers, black seed 2.5 g twice a day for 7 days strongly inhibited CYP2D6 and weakly inhibited CYP3A4, with the dextromethorphan-based CYP3A4 index changing 1.6-fold (Al-Jenoobi et al., 2010). In the laboratory, thymoquinone, the main active compound of black seed, inhibited platelet aggregation (Rukoyatkina et al., 2025). In rats given clopidogrel, black seed further prolonged bleeding time (Alkharfy et al., 2021). In humans, one case of an extensive subcutaneous haematoma has been reported. A man on dual antiplatelet therapy and chemotherapy, with a low platelet count, had raised his black seed oil dose to 2000 mg a day, and the authors rated the link with black seed as possible (Arab et al., 2026).

Symptoms

The most common adverse reactions to apixaban are bleeding, bruising, nosebleeds and haematomas, and occult bleeding in any organ can lead to anaemia (Eliquis SmPC, European Medicines Agency, EMA, section 4.8). In the reported black seed case, the haematoma appeared after the oil dose was increased and resolved within 10 days after all agents affecting haemostasis were stopped (Arab et al., 2026).

Management

The combination can be used with attention to bleeding. According to the apixaban SmPC, antiplatelet agents increase the risk of bleeding (Eliquis SmPC, European Medicines Agency, EMA, section 4.4). For black seed, such an effect has been shown in the laboratory and in animals, with one case reported in a human. The apixaban dose is not changed because of black seed: according to the SmPC, it is not adjusted with substances that are not strong inhibitors of CYP3A4 and P-glycoprotein (Eliquis SmPC, EMA, section 4.5). If unexplained bruising, bleeding gums, nosebleeds, blood in the urine or black stools appear, black seed is stopped and the source of bleeding is looked for. In severe bleeding, apixaban is interrupted (Eliquis SmPC, EMA, section 4.4).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Apixaban